Mercer Global Advisors »

Seres Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $292 37 7.89

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Capital Management
Marshall Wace
Susquehanna International
Vontobel Holding
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Lion Point Capital
Charles Schwab Investment Management
Sixth Street Partners Management Company
American Century Companies
Morgan Stanley

View all funds holding Seres Therapeutics